| Literature DB >> 27800441 |
Giuseppe Merialdi1, Mattia Ramini1, Giovanni Parolari2, Silvana Barbuti2, Maria Angela Frustoli2, Roberta Taddei1, Stefano Pongolini1, Paolo Ardigò1, Paolo Cozzolino3.
Abstract
The objective of this study was to investigate Clostridium botulinum growth and toxin production in the industrially manufactured Italian Parma ham. The study focuses on the Parma ham production phase identified as maximum risk to C. botulinum proliferation, i.e. the transition from cold phase (salting and resting) to a phase carried out at temperature between 15 and 23°C (drying). A preliminary in vitro test was carried out in order to verify the capability of 6 C. botulinum strains (1 type A, 4 type B, and 1 type E strains) to grow in conditions of temperature, pH and NaCl concentration comparable to those of the beginning stage of ham drying. Five C. botulinum strains grew at 20°C and pH 6, four strains produced toxin when inoculated at a concentration equal to 103 cfu/mL at NaCl concentration of 4%, while when the inoculum concentration was 10 cfu/mL, NaCl concentration of 3% resulted the toxin-genesis limiting factor. An experimental contamination with a mixture of the 5 C. botulinum strains selected by the preliminary in vitro test was performed on 9 thighs inoculated at the end of the resting phase. The study was designed to evaluate the potential growth and toxin production in extremely favourable conditions for the bacterium. Type B proteolytic C. botulinum toxin was produced after 14 days of incubation at 20°C in 2 thighs characterised by high weight, low number of days of resting and anomalous physiochemical characteristics [one for very low NaCl concentration (1.59%), the other for elevated pH (6.27) and both for high water activity values (>0.970)]. The results of this research confirm that the cold resting step is a critical phase in the production process of Parma ham for the investigated hazard. Based on the present study, the long resting phase adopted in the manufacturing of Parma ham is proven effective to prevent the growth of C. botulinum, an event which could not otherwise be excluded if the hams were processed under less stringent technological conditions.Entities:
Keywords: Botulism; Dry cured ham; Toxinogenesis
Year: 2016 PMID: 27800441 PMCID: PMC5076734 DOI: 10.4081/ijfs.2016.5564
Source DB: PubMed Journal: Ital J Food Saf ISSN: 2239-7132
Figure 1.Schematic diagram showing the production process of Parma ham.
Characteristics of the thighs included in the study.
| Thigh no. | Manufacturer | Days from salting | Weight (kg) | Effective duration of cold phase of the batch |
|---|---|---|---|---|
| 1 | A | 101 | 11.2 | 116 |
| 2 | B | 102 | 13.2 | 113 |
| 3 | C | 108 | 10.7 | 117 |
| 4 | D | 115 | 10.4 | 119 |
| 5 | E | 119 | 12.7 | 127 |
| 6 | A | 103 | 11.3 | 109 |
| 7 | A | 111 | 10.0 | 110 |
| 8 | C | 96 | 12.5 | 101 |
| 9 | E | 104 | 13.0 | 126 |
*In the production protocol of this ham 30% of NaCl has been replaced by KCl.
Combined effect of NaCl and inoculum concentrations on growth and toxin production of six Clostridium botulinum strains.
| Strain | Inoculum Concentration (cfu/mL) | NaCL (%) | Incubation time (days) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 28 | |||||||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| ATCC 19397 | 10 | 3 | G+TP | G+TP | / | / | / | / | / | / | G+TP | G+TP | / | / | / | / | / | / |
| 103 | 4 | G+TP | G+TP | / | / | / | / | / | / | G+TP | G+TP | G+TP | G+TP | / | / | / | / | |
| ATCC 17786 | 10 | 3 | G+TP | G+TP | G | / | / | / | / | / | G+TP | G+TP | G+TP | / | / | / | / | / |
| 103 | 4 | G+TP | G+TP | G+TP | / | / | / | / | / | G+TP | G+TP | G+TP | G+TP | / | / | / | / | |
| ATCC 17844 | 10 | 3 | G+TP | G+TP | / | / | / | / | / | / | G+TP | G+TP | G+TP | / | / | / | / | / |
| 103 | 4 | G+TP | G+TP | / | / | / | / | / | / | G+TP | G+TP | G+TP | G+TP | / | / | / | / | |
| 92331 IZSLER | 10 | 3 | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / |
| 103 | 4 | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | / | |
| 172977 IZSLER | 10 | 3 | G+TP | G+TP | G | / | / | / | / | / | G+TP | G+TP | G+TP | G | / | / | / | / |
| 103 | 4 | G+TP | G+TP | G | / | / | / | / | / | G+TP | G+TP | G+TP | G+TP | / | / | / | / | |
| 11793 IZSLER | 10 | 3 | G+TP | G+TP | G | / | / | / | / | / | G+TP | G+TP | G+TP | / | / | / | / | / |
| 103 | 4 | G+TP | G+TP | G | / | / | / | / | / | G+TP | G+TP | G+TP | / | / | / | / | / | |
G, growth; TP, toxin production.
Results of Clostridium botulinum growth in thighs after experimental contamination.
| Thigh no. | Sampling point | aw | pH | NaCl (%) | Initial | |||
|---|---|---|---|---|---|---|---|---|
| 7 dpc | 14 dpc | 21 dpc | ||||||
| 1 | Shank | 0.959 | 5.98 | 3.35 | 0.79 | 1.00 | 0.70 | 0.70 |
| Core | 0.955 | 5.97 | 3.74 | 0.79 | 0.70 | 0.70 | 0.70 | |
| Butt | 0.943 | 5.96 | 4.89 | 0.79 | 1.00 | 0.70 | 0.402 | |
| 2 | Shank | 0.975 | 5.78 | 1.59 | 0.79 | 2.76 | 5.35 | 5.35 |
| Core | 0.973 | 5.79 | 2.00 | 0.79 | 1.00 | 4.62 | 4.60 | |
| Butt | 0.957 | 6.17 | 3.45 | 0.79 | 0.70 | 1.00 | 1.00 | |
| 3 | Shank | 0.966 | 5.78 | 2.61 | 0.85 | 1.00 | 1.15 | 0.78 |
| Core | 0.969 | 5.73 | 2.62 | 0.85 | 0.85 | 1.00 | 1.18 | |
| Butt | 0.954 | 5.80 | 5.73 | 0.85 | 1.00 | 0.70 | 1.18 | |
| 4 | Shank | 0.962 | 5.85 | 3.17 | 0.85 | 1.00 | 0.70 | 0.70 |
| Core | 0.967 | 5.69 | 3.02 | 0.85 | 1.08 | 1.04 | 0.70 | |
| Butt | 0.912 | 5.67 | 7.25 | 0.85 | 0.70 | 0.70 | 1.00 | |
| 5 | Shank | 0.972 | 5.73 | 2.51 | 0.80 | 1.00 | 1.00 | 1.00 |
| Core | 0.973 | 5.89 | 2.26 | 0.80 | 0.85 | 1.15 | 0.70 | |
| Butt | 0.943 | 6.11 | 5.24 | 0.80 | 0.85 | 1.30 | 1.00 | |
| 6 | Shank | 0.966 | 6.09 | 3.32 | 1.01 | 1.30 | 1.23 | 1.18 |
| Core | 0.968 | 5.78 | 4.44 | 1.01 | 1.00 | 1.00 | 1.18 | |
| Butt | 0.967 | 5.90 | 4.75 | 1.01 | 1.30 | 1.40 | 1.30 | |
| 7 | Shank | 0.967 | 5.80 | 2.78 | 1.01 | 1.40 | 1.00 | 1.00 |
| Core | 0.954 | 5.88 | 3.19 | 1.01 | 1.30 | 1.30 | 1.20 | |
| Butt | 0.954 | 5.82 | 5.11 | 1.01 | 1.30 | 1.30 | 1.00 | |
| 8 | Shank | 0.964 | 5.70 | 2.26 | 0.75 | 1.00 | 0.70 | 0.70 |
| Core | 0.964 | 5.58 | 2.35 | 0.75 | 1.00 | 1.00 | 0.70 | |
| Butt | 0.955 | 5.85 | 3.73 | 0.75 | 1.00 | 1.30 | 1.30 | |
| 9 | Shank | 0.970 | 6.27 | 2.48 | 0.75 | 3.30 | 5.02 | 5.40 |
| Core | 0.966 | 5.72 | 2.82 | 0.75 | 1.00 | 1.00 | 0.70 | |
| Butt | 0.949 | 5.86 | 4.69 | 0.75 | 0.70 | 0.70 | 0.70 | |
C. botulinum, Clostridium botulinum; dpc, days post contamination.
Figure 2.Clostridium botulinum multiplication (A) and physiochemical characteristics (B) of the tested thighs. Empty circles represent samples where Clostridium botulinum multiplication did not occur.